REQUEST A DEMO
Total
USD $0.00
Search more companies

Jivandhara Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jivandhara Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Jivandhara Pharma Private Limited is a company in India, with a head office in Navsari. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on July 17, 2003. From the latest financial highlights, Jivandhara Pharma Private Limited reported a net sales revenue increase of 15.21% in 2024. Its total assets grew by 9.25% over the same period. Jivandhara Pharma Private Limited’s net profit margin increased by 0.75% in 2024.

Legal Address
Shop No 30 To 37, 1/292, Ground Floor, Hormzad Baug, Somnath Road,
Navsari; Gujarat; Postal Code: 396321

Contact Details: Purchase the Jivandhara Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Jivandhara Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Jivandhara Pharma Private Limited report to view the information.
Incorporation Date:
July 17, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Jivandhara Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
15.21%
Total Operating Revenue
15.09%
Operating Profit
61.37%
EBITDA
50.99%
Net Profit/Loss for the Period
140.81%
Total Assets
9.25%
Total Equity
19.8%
Operating Profit Margin
0.69%
Net Profit Margin
0.75%
Return on Equity (ROE)
8.31%
Debt / Equity
3.14%
Quick Ratio
0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?